secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axogen, Inc. (AXGN)
CIK:        0000805928
Form:       8-K
Filed at:   2023-12-26T23:59:59+00:00
Accession:  0000805928-23-000156
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axogen appoints Kathy Weiler to its board, effective Dec 20, 2023
-----------------------------------------------------------------

- Board expanded to 10; Weiler serves on Governance, Nominating & Sustainability and Quality, Compliance & Portfolio committees.
- Weiler is EVP, Chief Commercial & Growth Officer at Amwell (NYSE: AMWL); 20+ years in healthcare commercial leadership.
- Initial stock option grant of $275k value vesting over 3 years; annual equity grants of $150k (half options, half RSUs) vesting 1 year.
- Compensation includes quarterly cash retainer of $10,000 plus $1,250 per committee served.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/805928/000080592823000156/0000805928-23-000156-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/805928/000080592823000156/axgn-20231220.htm
  HTML page:      https://secwatch.observer/filing/0000805928-23-000156

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer